rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jacque J. Sokolov

Director

Company insider

Files Form 4 as: Director, Lucid Diagnostics; Director, Hospira; Director, Medcath.

In numbers

Trades disclosed
52
Buys
2
Sells
1
Bought
$245K
Sold
$455K
Companies
3
Companies where not an officer
3
First trade
30 Jun 2006
Last trade
20 Feb 2026
Last filed
24 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LUCD Lucid DiagnosticsDirector · Diagnostics & Labs · last 20 Feb 20260 buys · 0 sells
HospiraDirector · last 3 Sep 20151 buy · 1 sell
MedcathDirector · last 24 Aug 20121 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Feb 2026filed 24 Feb 2026LUCD Lucid DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—123,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026LUCD Lucid DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—123,000 at $0.00filing
20 Feb 2025filed 21 Feb 2025LUCD Lucid DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—112,800 at $0.00filing
22 Feb 2024filed 23 Feb 2024LUCD Lucid Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—150,000 at $0.00filing
31 Jan 2023filed 2 Feb 2023LUCD Lucid Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—175,000 at $0.00filing
18 Feb 2022filed 24 Feb 2022LUCD Lucid Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—59,000 at $0.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code D$3.6M40,078.69 at $90.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code D$270K3,000 at $90.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code D$90K1,000 at $90.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code D$90K1,000 at $90.00filing
30 Jun 2015filed 1 Jul 2015HospiraSEC FORM 4 Code A—253.69 at $0.00filing
31 Mar 2015filed 1 Apr 2015HospiraSEC FORM 4 Code A—256.21 at $0.00filing
25 Feb 2015filed 27 Feb 2015HospiraSEC FORM 4 Code A—2,171 at $0.00filing
25 Feb 2015filed 27 Feb 2015HospiraSEC FORM 4 Code A—9,999 at $0.00filing
31 Dec 2014filed 4 Feb 2015HospiraSEC FORM 4 Code A$2,00032.27 at $61.98filing
31 Dec 2014filed 15 Jan 2015HospiraSEC FORM 4 Code A—322.68 at $0.00filing
28 Nov 2014filed 2 Dec 2014HospiraSEC FORM 4 Sold$455K7,547 at $60.32filing
30 Sep 2014filed 1 Oct 2014HospiraSEC FORM 4 Code A—406.23 at $0.00filing
30 Jun 2014filed 1 Jul 2014HospiraSEC FORM 4 Code A—415.85 at $0.00filing
31 Mar 2014filed 26 Aug 2015HospiraSEC FORM 4 Code A—494.07 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Dennis MatheisDirector · Director at Lucid Diagnostics, filing Form 4 there in the last year
Dennis M. McGrathDirector · Chief Financial Officer at Lucid Diagnostics, filing Form 4 there in the last year
Lishan AklogChairman and CEO · Chief Executive Officer at Lucid Diagnostics, filing Form 4 there in the last year
Ronald M. SparksDirector · Director at Lucid Diagnostics, filing Form 4 there in the last year
James L. CoxDirector · Director at Lucid Diagnostics, filing Form 4 there in the last year